The Top 100 Cited Research Instruments: 2026 Analysis
5
Min Read
In this blog:
- 24 suppliers ranked in the Top 100 Cited Instrument list
- Flow cytometers, optical microscopes, and legacy platforms are highly referenced in the literature
- Download data on the top 100 Research Instruments for your own analysis and to see if you rank!
CiteAb collects information on product use in the scientific literature, curating an industry-leading life science reagent database that powers data services for suppliers & pharma companies, and a search platform to help scientists find the right products, faster.
Welcome to CiteAb’s Top 100 series for 2026!
This is our first ever Top 100 Instruments Report, where we rank the most-cited instruments in research over the past year.
Read on for insights into the most used instruments in the life sciences, and the companies providing them.
Data & Methodology
Launching as a new dataset on CiteAb this year, we have now collected information on nearly 2700 analytical instruments – covering flow cytometers, microscopes, mass spectrometers and more – from nearly 100 suppliers.
We specifically focus on citation counts: a measure of how frequently a product appears in peer-reviewed, published research. This data helps researchers see what their peers are reaching for, and gives suppliers a leading indicator of future demand as well as insight into past research activity.
This analysis draws from a year’s worth of data, across all suppliers and all instrument types, ranking products by citation count .
The Instrument Suppliers Supporting A Significant Volume of Research
Top 100 rankings were dominated by just a few companies
Overall, we saw 24 suppliers in the Top 100 Cited Instrument list – showing the market to be competitive at the top.
However, when we drilled down, we found that around half of the Top 100 list is supplied by 4 vendors. They were:
- BD Biosciences
- Evident Scientific
- Zeiss
- ThermoFisher
Interestingly, when you combine brands under the same company, Danaher jumps to the top of the Top 100 list. This is a clear illustration of how M&A strategy lets a single company cover multiple niches to build overall strength.
We also saw clear specialisation across the market:
- Imaging specialists: Leica, Nikon
- Flow specialists: BD, Cytek
- Gel and blot imaging systems: Bio-Rad
- Broader, multi-category players: Bruker
Furthermore, we noted that innovation isn’t concentrated in one region. Supplier HQs span the US, Europe, and Japan.
The Top Cited Research Instruments Leading the Market
Taking a birds eye view of the market, we found that the Top 100 Instrument rankings were broadly split as follows: 20% for cell characterisation, 26% for cell/tissue imaging/visualisation, and 10% analytical tools driving omics, multi-omics and more.
The top cited instrument was the D8 Advance, an X-ray diffractometer supplied by Bruker, commonly used in materials science, analytical sciences and chemistry research. It is perhaps unsurprising this tool tops the list given its use across multiple disciplines.
Flow cytometers rank strongly by citation share
Flow instruments – cell characterisation tools- claimed a strong showing in the Top 100, with 20 instruments from 4 different suppliers, and 17 flow cytometers.
The most cited active model was BD LSRFortessa™, ranking at number five, from BD Biosciences (now Waters Bioscience). In fact, Waters Bioscience saw 11 of the 20 ranking flow instruments.
This is perhaps unsurprising, given Waters Bioscience has convincingly led the flow space for many years, as we commented on in our flow analysis earlier this year.
In that same analysis we pulled out Cytek Biosciences and Sony Biotech as companies with impressive growth trajectories.
We found that Cytek also ranked in the Top 20 in this report with their Aurora instrument – a spectral flow cytometer – reinforcing that trend, and going to show how innovation can lead to disruption of the market.
Optical microscopy instruments make up a roughly quarter of the Top 100
Moving on to optical microscopes – in the cell imaging category – we found this type of instrument populated around a quarter of the Top 100. Instruments included confocal and Upright/inverted microscopes from Zeiss, Evident Scientific, Leica and Nikon.
The most cited confocal microscope, ranking in the Top 10, was LSM 880 from Zeiss, and the most cited upright/inverted microscope platform BX53 from Evident Scientific.
Mass spectrometry instruments perform strongly
The third prominent category of instrument in the Top 100 were analytical tools. 8 of the 10 that ranked in the Top 100 were from Thermo Fisher Scientific.
Beyond the top three instrument types
The Top 100 data also revealed further, perhaps more surprising, insights.
- DNA Sequencing Instruments underrepresented
We were interested to see that only 4 instruments for DNA sequencing made the Top 100 rankings by citation share. This may be due to researchers outsourcing their sequencing to commercial providers and partners, as opposed to citing the instrument itself.
- Legacy instruments still hold their ground
Across all instrument categories, we found that legacy models still appeared in the Top 100.
In fact, 22 of the Top 100 were legacy models that have been discontinued. Notable examples included:
- AVANCE III NMR spectrometer #2 (end of service since 2024)
- Avance II NMR spectrometer #70 (end of service since 2018)
This shows that instruments can go on supporting research for many years after they are no longer sold. This could be due to manufacturers providing service in some cases even after the end of sale, or in-house staff knowledge ensuring instrument reliability.
We noted that the successor for these instruments, such as the AVANCE III HD, also ranked in the Top 100 at number 12. The inclusion of a newer model alongside their legacy counterparts shows adoption of new tools is happening – just with a lag.
Interested in understanding how instruments citations link to reagent consumable citations, and which instruments are being cited beyond the Top 100? Get in touch with the team here.
Wrap-up and Data Download
Below, you can freely download the complete list of the Top 100 Cited Research Instruments for your own analysis, and to see where you rank.
Dr Andrew Chalmers, CEO of CiteAb, commented:
“Having launched our instrument dataset early in 2026, we’ve already seen some fascinating insights emerge from the citation data. This new report shows a large variety of players with top cited instruments – highlighting the strong competition in the space. We were interested to see share of the Top 100 relatively concentrated – and will be watching the space to see how suppliers innovate to break into the top rankings within these well established market niches.”
Don’t forget, you can dig into more Top 100 Reports by following one of the links below:
- Top 100 Research Protein Report
- Top 100 Bioactive Small Molecules Report
- Top 100 Life Science Kits & Assays Report
- Top 100 Cell Lines Report
- Top 100 Research Antibody Report
Sign up for data
Something seems to have gone wrong while loading the form.
Drop us a message and we can send you the data directly.
FAQs
The Top 100 Cited Instrument List is built by mining our database of instrument mentions across life science publications. We rank instruments by their share of citations over the previous year to produce the final ranking.
2026 is the first year we are including the top 100 instrument analysis, to mark the launch of our Instrument Dataset earlier this year. We will be updating it on an annual basis moving forward.
Sales figures are proprietary to each manufacturer, while citation data spans the full market of instruments used in published research, giving a benchmark that works across the whole industry. Citations signal where demand is heading – making them a leading indicator, unlike sales data which reflects what’s already happened.
Citation data reveals how instruments are actually being used in the field and where interest is building next, including which consumables are being used with specific platforms. That gives product teams a head start when shaping their roadmap or catalogue strategy, supports benchmarking against the wider market, and equips sales and marketing teams with valuable insights.
